menu
    • menu

    Company profile for Moderna Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Moderna is a leader in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating mRNA medicines for a wide range of diseases and conditions, in many ...
    Moderna is a leader in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating mRNA medicines for a wide range of diseases and conditions, in many cases by addressing currently undruggable targets or underserved areas of medical need. Moderna is developing its innovative mRNA medicines for infectious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moderna TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Technology Sq, Cambridge, Massachusetts 02139, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.modernatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/moderna-/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moderna secures up to $54.3M funding for bird flu vaccine
    Moderna secures up to $54.3M funding for bird flu vaccine

    18 Dec 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-secures-up-543-million-funding-bird-flu-vaccine-global-coalition-2025-12-18/

    REUTERS
    18 Dec 2025
    Share Share
    Moderna To Present At 44th J.P. Morgan Healthcare Conference
    Moderna To Present At 44th J.P. Morgan Healthcare Conference

    17 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-17/moderna-to-present-at-the-44th-annual-jp-morgan-healthcare-conference

    PHARMIWEB
    17 Dec 2025
    Share Share
    Moderna's $500M pact with Nanexa to improve injectables delivery
    Moderna's $500M pact with Nanexa to improve injectables delivery

    11 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/moderna-taps-nanexa-improve-delivery-injectable-therapies-back-loaded-500m-pact

    FIERCE BIOTECH
    11 Dec 2025
    Share Share
    Moderna secures $1.5B loan, eyes cash breakeven in 2028
    Moderna secures $1.5B loan, eyes cash breakeven in 2028

    21 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/moderna-takes-15b-loan-outlines-new-commercial-and-rd-strategy-bid-break-even-2028

    FIERCE PHARMA
    21 Nov 2025
    Share Share
    Moderna Showcases Pipeline Progress And Business Strategy
    Moderna Showcases Pipeline Progress And Business Strategy

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/moderna-analyst-day-highlights-pipeline-progress-and-business-strategy-updates

    PHARMIWEB
    20 Nov 2025
    Share Share
    Moderna Winds Down 3 mRNA Programs
    Moderna Winds Down 3 mRNA Programs

    20 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges

    FIERCE BIOTECH
    20 Nov 2025
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search